{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:12:35Z","timestamp":1790903555700,"version":"4.1.0"},"reference-count":140,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,1,1]]},"DOI":"10.1093\/alcalc\/agh110","type":"journal-article","created":{"date-parts":[[2004,11,18]],"date-time":"2004-11-18T20:13:04Z","timestamp":1100808784000},"page":"2-14","source":"Crossref","is-referenced-by-count":311,"title":["THE ENDOCANNABINOID SYSTEM: PHYSIOLOGY AND PHARMACOLOGY"],"prefix":"10.1093","volume":"40","author":[{"given":"FERNANDO","family":"RODR\u00cdGUEZ de FONSECA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IGNACIO","family":"DEL ARCO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FRANCISCO JAVIER","family":"BERMUDEZ-SILVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AINHOA","family":"BILBAO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANDREA","family":"CIPPITELLI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MIGUEL","family":"NAVARRO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2004,11,18]]},"reference":[{"key":"key\n\t\t\t\t20171011104327_B1","doi-asserted-by":"crossref","unstructured":"Basavarajappa, B. S., Cooper, T. B. and Hungund, B. L. (1998) Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membrane. Brain Research793, 212\u2013218.","DOI":"10.1016\/S0006-8993(98)00175-9"},{"key":"key\n\t\t\t\t20171011104327_B2","doi-asserted-by":"crossref","unstructured":"Basavarajappa, B. S. and Hungund, B. L. (1999) Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidyl-ethanolamine in SK-N-SH cells. Journal of Neurochemistry72, 522\u2013528.","DOI":"10.1046\/j.1471-4159.1999.0720522.x"},{"key":"key\n\t\t\t\t20171011104327_B3","doi-asserted-by":"crossref","unstructured":"Basavarajappa, B. S., Saito, M., Cooper, T. B. and Hungund, B. L. (2000) Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. Biochimica et Biophysica Acta1535, 78\u201386.","DOI":"10.1016\/S0925-4439(00)00085-5"},{"key":"key\n\t\t\t\t20171011104327_B4","doi-asserted-by":"crossref","unstructured":"Batkai, S., Jarai, Z., Wagner, J. A. et al. (2001) Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nature Medicine7, 827\u2013832.","DOI":"10.1038\/89953"},{"key":"key\n\t\t\t\t20171011104327_B5","doi-asserted-by":"crossref","unstructured":"Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A. and Piomelli, D. (1997) Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science277, 1094\u20131097.","DOI":"10.1126\/science.277.5329.1094"},{"key":"key\n\t\t\t\t20171011104327_B6","doi-asserted-by":"crossref","unstructured":"Beinfeld, M. C. and Connolly, K. (2001) Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids. Neuroscience Letters301, 69\u201371.","DOI":"10.1016\/S0304-3940(01)01591-9"},{"key":"key\n\t\t\t\t20171011104327_B7","doi-asserted-by":"crossref","unstructured":"Bisogno, T., Howell, F., Williams, G. et al. (2003) Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signalling in the brain. Journal of Cell Biology163, 463\u2013468.","DOI":"10.1083\/jcb.200305129"},{"key":"key\n\t\t\t\t20171011104327_B8","doi-asserted-by":"crossref","unstructured":"Boger, D. L., Sato, H., Lerner, A. E. et al. (2000) Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide. Proceedings of the National Academy of Sciences of the United States of America97, 5044\u20135049.","DOI":"10.1073\/pnas.97.10.5044"},{"key":"key\n\t\t\t\t20171011104327_B9","doi-asserted-by":"crossref","unstructured":"Bouaboula, M., Perrachon, S., Milligan, L. et al. (1997) A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor\/ligand interactions. Journal of Biological Chemistry272, 22330\u201322339.","DOI":"10.1074\/jbc.272.35.22330"},{"key":"key\n\t\t\t\t20171011104327_B10","doi-asserted-by":"crossref","unstructured":"Breivogel, C. S. and Childers, S. R. (1998) The functional neuroanatomy of brain cannabinoid receptors. Neurobiology of Disease5, 417\u2013431.","DOI":"10.1006\/nbdi.1998.0229"},{"key":"key\n\t\t\t\t20171011104327_B11","doi-asserted-by":"crossref","unstructured":"Breivogel, C. S., Selley, D. E. and Childers, S. R. (1998) Cannabinoid receptor agonist efficacy for stimulating [35S]GTP\u03b3S binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity. Journal of Biological Chemistry273, 16865\u201316873.","DOI":"10.1074\/jbc.273.27.16865"},{"key":"key\n\t\t\t\t20171011104327_B12","doi-asserted-by":"crossref","unstructured":"Cadas, H., Gaillet, S., Beltramo, M., Venance, L. and Piomelli, D. (1996) Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. Journal of Neuroscience16, 3934\u20133942.","DOI":"10.1523\/JNEUROSCI.16-12-03934.1996"},{"key":"key\n\t\t\t\t20171011104327_B13","doi-asserted-by":"crossref","unstructured":"Cabral, G. A. (2001) Marijuana and cannabinoids: effects on infections, immunity and AIDS. Journal of Cannabis Therapeutics1, 61\u201385.","DOI":"10.1300\/J175v01n03_06"},{"key":"key\n\t\t\t\t20171011104327_B14","doi-asserted-by":"crossref","unstructured":"Calignano, A., La Rana, G., Giuffrida, A. and Piomelli, D. (1998) Control of pain initiation by endogenous cannabinoids. Nature394, 277\u2013281.","DOI":"10.1038\/28393"},{"key":"key\n\t\t\t\t20171011104327_B15","doi-asserted-by":"crossref","unstructured":"Calignano, A., La Rana, G., Loubet-Lescoulie, P. and Piomelli, D. (2000) A role for the endogenous cannabinoid system in the peripheral control of pain initiation. Progress in Brain Research129, 471\u2013482.","DOI":"10.1016\/S0079-6123(00)29034-1"},{"key":"key\n\t\t\t\t20171011104327_B16","doi-asserted-by":"crossref","unstructured":"Casanova, M. L., Blazquez, C., Martinez-Palacio, J., Villanueva, C., Fernandez-Acenero, M. J., Huffman, J. W., Jorcano, J. L. and Guzman, M. (2003) Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. Journal of Clinical Investigation111, 43\u201350.","DOI":"10.1172\/JCI200316116"},{"key":"key\n\t\t\t\t20171011104327_B17","doi-asserted-by":"crossref","unstructured":"Castellano, C., Rossi-Arnaud, C., Cestari, V. and Costanzi, M. (2003) Cannabinoids and memory: animal studies. Current Drug Targets \u2014 CNS & Neurological Disorders2, 389\u2013402.","DOI":"10.2174\/1568007033482670"},{"key":"key\n\t\t\t\t20171011104327_B18","doi-asserted-by":"crossref","unstructured":"Chaperon, F. and Thi\u00e9bot, M.-H. (1999) Behavioral effects of cannabinoid agents in animals. Critical Reviews in Neurobiology13, 243\u2013281.","DOI":"10.1615\/CritRevNeurobiol.v13.i3.20"},{"key":"key\n\t\t\t\t20171011104327_B19","doi-asserted-by":"crossref","unstructured":"Chevaleyre, V. and Castillo, P. E. (2003) Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron38, 461\u2013472.","DOI":"10.1016\/S0896-6273(03)00235-6"},{"key":"key\n\t\t\t\t20171011104327_B20","doi-asserted-by":"crossref","unstructured":"Childers, S. R. and Deadwyler, S. A. (1996) Role of cyclic AMP in the actions of cannabinoid receptors. Biochemical Pharmacology52, 819\u2013827.","DOI":"10.1016\/0006-2952(96)00419-4"},{"key":"key\n\t\t\t\t20171011104327_B21","doi-asserted-by":"crossref","unstructured":"Colombo, G., Agabio, R., Fa, M., Guano, L., Lobina, C., Loche, A., Reali, R. and Gessa, G. L. (1998) Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716. Alcohol and Alcoholism33, 126\u2013130.","DOI":"10.1093\/oxfordjournals.alcalc.a008368"},{"key":"key\n\t\t\t\t20171011104327_B22","doi-asserted-by":"crossref","unstructured":"Colombo, G., Serra, S., Brunetti, G., G\u00f3mez, R., Melis, S., Vacca, G., Carai, M. M., and Gessa, G. L. (2002) Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats. Psychopharmacology159, 181\u2013187.","DOI":"10.1007\/s002130100887"},{"key":"key\n\t\t\t\t20171011104327_B23","doi-asserted-by":"crossref","unstructured":"Comings, D. E., Muhleman, D., Gade, R., Johnson, P., Verde, R., Saucier, G., and MacMurray, J. (1997) Cannabinoid receptor gene (CNR1): association with i.v. drug use. Molecular Psychiatry2, 161\u2013168.","DOI":"10.1038\/sj.mp.4000247"},{"key":"key\n\t\t\t\t20171011104327_B24","doi-asserted-by":"crossref","unstructured":"Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R. and Lichtman, A. H. (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signalling in mice lacking fatty acid amide hydrolase. Proceedings of the National Academy of Sciences of the United States America98, 9371\u20139376.","DOI":"10.1073\/pnas.161191698"},{"key":"key\n\t\t\t\t20171011104327_B25","doi-asserted-by":"crossref","unstructured":"Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., and Gilula, N. B. (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature384, 83\u201387.","DOI":"10.1038\/384083a0"},{"key":"key\n\t\t\t\t20171011104327_B26","doi-asserted-by":"crossref","unstructured":"Cravatt, B. F. and Lichtman, A. H. (2003) Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. Current Opinion in Chemical Biology7, 469\u2013475.","DOI":"10.1016\/S1367-5931(03)00079-6"},{"key":"key\n\t\t\t\t20171011104327_B27","doi-asserted-by":"crossref","unstructured":"De Lago, E., Fernandez-Ruiz, J., Ortega-Gutierrez, S., Viso, A., Lopez-Rodriguez, M. L. and Ramos, J. A. (2002) UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide. European Journal of Pharmacology449, 99\u2013103.","DOI":"10.1016\/S0014-2999(02)01996-9"},{"key":"key\n\t\t\t\t20171011104327_B28","doi-asserted-by":"crossref","unstructured":"De Petrocellis, L., Cascio, M. G. and Di Marzo, V. (2004) The endocannabinoid system: a general view and latest additions. British Journal of Pharmacology141, 765\u2013774.","DOI":"10.1038\/sj.bjp.0705666"},{"key":"key\n\t\t\t\t20171011104327_B29","doi-asserted-by":"crossref","unstructured":"Derkinderen, P., Toutant, M., Burgaya, F., Le Bert, M., Siciliano, J. C., De Franciscis, V., Gelman, M. and Girault, J. A. (1996) Regulation of a neuronal form of focal adhesion kinase by anandamide. Science273, 1719\u20131722.","DOI":"10.1126\/science.273.5282.1719"},{"key":"key\n\t\t\t\t20171011104327_B30","unstructured":"Devane, W. A., Dysarz, F. A. 3rd, Johnson, M., Melvin, L. S. and Howlett, A. C. (1988) Determination and characterization of a cannabinoid receptor in rat brain. Molecular Pharmacology34, 605\u2013613."},{"key":"key\n\t\t\t\t20171011104327_B31","doi-asserted-by":"crossref","unstructured":"Devane, W. A., Hanus, L., Breuer, A. et al. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science258, 1946\u20131949.","DOI":"10.1126\/science.1470919"},{"key":"key\n\t\t\t\t20171011104327_B32","doi-asserted-by":"crossref","unstructured":"De Vries, T. J., Homberg, J. R., Binnekade, R., Raaso, H. and Schoffelmeer, A. N. (2003) Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats. Psychopharmacology168, 164\u2013169.","DOI":"10.1007\/s00213-003-1422-1"},{"key":"key\n\t\t\t\t20171011104327_B33","doi-asserted-by":"crossref","unstructured":"De Vries, T. J., Shaham, Y., Homberg, J. R., Crombag, H., Schuurman, K., Dieben, J., Vanderschuren, L. J. and Schoffelmeer, A. N. (2001) A cannabinoid mechanism in relapse to cocaine seeking. Nature Medicine7, 1151\u20131154.","DOI":"10.1038\/nm1001-1151"},{"key":"key\n\t\t\t\t20171011104327_B34","doi-asserted-by":"crossref","unstructured":"Diana, M. A., Levenes, C., Mackie, K. and Marty, A. (2002) Short-term retrograde inhibition of GABAergic synaptic currents in rat Purkinje cells is mediated by endogenous cannabinoids. Journal of Neuroscience22, 200\u2013208.","DOI":"10.1523\/JNEUROSCI.22-01-00200.2002"},{"key":"key\n\t\t\t\t20171011104327_B35","doi-asserted-by":"crossref","unstructured":"Diana, M. A. and Marty, A. (2004) Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). British Journal of Pharmacology142, 9\u201319.","DOI":"10.1038\/sj.bjp.0705726"},{"key":"key\n\t\t\t\t20171011104327_B36","doi-asserted-by":"crossref","unstructured":"Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J. C. and Piomelli, D. (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature372, 686\u2013691.","DOI":"10.1038\/372686a0"},{"key":"key\n\t\t\t\t20171011104327_B37","doi-asserted-by":"crossref","unstructured":"Di Marzo, V., Goparaju, S. K., Wang, L. et al. (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature410, 822\u2013825.","DOI":"10.1038\/35071088"},{"key":"key\n\t\t\t\t20171011104327_B38","doi-asserted-by":"crossref","unstructured":"Di Marzo, V., Melck, D., Bisogno, T. and De Petrocellis, L. (1998) Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends in Neurosciences21, 521\u2013528.","DOI":"10.1016\/S0166-2236(98)01283-1"},{"key":"key\n\t\t\t\t20171011104327_B39","doi-asserted-by":"crossref","unstructured":"Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S. and Piomelli, D. (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proceedings of the National Academy of Sciences of the United States of America99, 10819\u201310824.","DOI":"10.1073\/pnas.152334899"},{"key":"key\n\t\t\t\t20171011104327_B40","doi-asserted-by":"crossref","unstructured":"Egertova, M., Cravatt, B. F. and Elphick, M. R. (2003) Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling. Neuroscience119, 481\u2013496.","DOI":"10.1016\/S0306-4522(03)00145-3"},{"key":"key\n\t\t\t\t20171011104327_B41","doi-asserted-by":"crossref","unstructured":"Elphick, M. R. and Egertova, M. (2001) The neurobiology and evolution of cannabinoid signalling. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences356, 381\u2013408.","DOI":"10.1098\/rstb.2000.0787"},{"key":"key\n\t\t\t\t20171011104327_B42","doi-asserted-by":"crossref","unstructured":"Fegley, D., Kathuria, S., Mercier, R., Li, C., Goutopoulos, A., Makriyannis, A. and Piomelli, D. (2004) Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proceedings of the National Academy of Sciences of the United States of America101, 8756\u20138761.","DOI":"10.1073\/pnas.0400997101"},{"key":"key\n\t\t\t\t20171011104327_B43","doi-asserted-by":"crossref","unstructured":"Felder, C. C. and Glass, M. (1998) Cannabinoid receptors and their endogenous agonists. Annual Review of Pharmacology and Toxicology38, 179\u2013200.","DOI":"10.1146\/annurev.pharmtox.38.1.179"},{"key":"key\n\t\t\t\t20171011104327_B44","unstructured":"Felder, C. C., Joyce, K. E., Briley, E. M. et al. (1998) LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation. Journal of Pharmacology and Experimental Therapeutics284, 291\u2013297."},{"key":"key\n\t\t\t\t20171011104327_B45","doi-asserted-by":"crossref","unstructured":"Fernandez-Ruiz, J., Berrendero, F., Hernandez, M. L. and Ramos, J. A. (2000) The endogenous cannabinoid system and brain development. Trends in Neurosciences23, 14\u201320.","DOI":"10.1016\/S0166-2236(99)01491-5"},{"key":"key\n\t\t\t\t20171011104327_B46","doi-asserted-by":"crossref","unstructured":"Freund, T. F., Katona, I. and Piomelli, D. (2003) Role of endogenous cannabinoids in synaptic signaling. Physiological Reviews83, 1017\u20131066.","DOI":"10.1152\/physrev.00004.2003"},{"key":"key\n\t\t\t\t20171011104327_B47","doi-asserted-by":"crossref","unstructured":"Fu, J., Gaetani, S., Oveisi, F. et al. (2003) Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature425, 90\u201393.","DOI":"10.1038\/nature01921"},{"key":"key\n\t\t\t\t20171011104327_B48","doi-asserted-by":"crossref","unstructured":"Gali\u00e8gue, S., Mary, S., Marchand, J., Dussossoy, D., Carri\u00e8re, D., Carayon, P., Bouaboula, M., Shire, D., Le Fur, G. and Casellas, P. (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. European Journal of Biochemistry232, 54\u201361.","DOI":"10.1111\/j.1432-1033.1995.tb20780.x"},{"key":"key\n\t\t\t\t20171011104327_B49","doi-asserted-by":"crossref","unstructured":"Galve-Roperh, I., Sanchez, C., Cortes, M. L., del Pulgar, T. G., Izquierdo, M. and Guzman, M. (2000) Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nature Medicine6, 313\u2013319.","DOI":"10.1038\/73171"},{"key":"key\n\t\t\t\t20171011104327_B50","doi-asserted-by":"crossref","unstructured":"Gaoni, Y. and Mechoulam, R. (1964) Isolation, structure and partial synthesis of an active constituent of hashish. Journal of the American Chemical Society86, 1646\u20131647.","DOI":"10.1021\/ja01062a046"},{"key":"key\n\t\t\t\t20171011104327_B51","doi-asserted-by":"crossref","unstructured":"Gardner, E. L. and Vorel, S. R. (1998) Cannabinoid transmission and reward-related events. Neurobiology of Disease5, 502\u2013533.","DOI":"10.1006\/nbdi.1998.0219"},{"key":"key\n\t\t\t\t20171011104327_B52","doi-asserted-by":"crossref","unstructured":"Gebremedhin, D., Lange, A. R., Campbell, W. B., Hillard, C. J. and Harder, D. R. (1999) Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current. American Journal of Physiology276, H2085\u20132093.","DOI":"10.1152\/ajpheart.1999.276.6.H2085"},{"key":"key\n\t\t\t\t20171011104327_B53","doi-asserted-by":"crossref","unstructured":"Gerdeman, G. L., Ronesi, J. and Lovinger, D. M. (2002) Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nature Neuroscience5, 446\u2013451.","DOI":"10.1038\/nn832"},{"key":"key\n\t\t\t\t20171011104327_B54","unstructured":"Giuffrida, A., Beltramo, M. and Piomelli, D. (2001) Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. Journal of Pharmacology and Experimental Therapeutics298, 7\u201314."},{"key":"key\n\t\t\t\t20171011104327_B55","doi-asserted-by":"crossref","unstructured":"Giuffrida, A., Parsons, L. H., Kerr, T. M., Rodriguez de Fonseca, F., Navarro, M. and Piomelli, D. (1999) Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nature Neuroscience2, 358\u2013363.","DOI":"10.1038\/7268"},{"key":"key\n\t\t\t\t20171011104327_B56","doi-asserted-by":"crossref","unstructured":"Gomez, R., Navarro, M., Ferrer, B. et al. (2002) A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. Journal of Neuroscience22, 9612\u20139617.","DOI":"10.1523\/JNEUROSCI.22-21-09612.2002"},{"key":"key\n\t\t\t\t20171011104327_B57","doi-asserted-by":"crossref","unstructured":"Gulyas, A. I., Cravatt, B. F., Bracey, M. H., Dinh, T. P., Piomelli, D., Boscia, F. and Freund, T. F. (2004) Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. European Journal of Neuroscience20, 441\u2013458.","DOI":"10.1111\/j.1460-9568.2004.03428.x"},{"key":"key\n\t\t\t\t20171011104327_B58","doi-asserted-by":"crossref","unstructured":"Guzman, M. (2003) Cannabinoids: potential anticancer agents. Nature Reviews Cancer3, 745\u2013755.","DOI":"10.1038\/nrc1188"},{"key":"key\n\t\t\t\t20171011104327_B59","doi-asserted-by":"crossref","unstructured":"Hajos, N., Ledent, C. and Freund, T. F. (2001) Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience106, 1\u20134.","DOI":"10.1016\/S0306-4522(01)00287-1"},{"key":"key\n\t\t\t\t20171011104327_B60","doi-asserted-by":"crossref","unstructured":"Hanus, L., Breuer, A., Tchilibon et al. (1999) HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor. Proceedings of the National Academy of Sciences of the United States of America96, 14228\u201314233.","DOI":"10.1073\/pnas.96.25.14228"},{"key":"key\n\t\t\t\t20171011104327_B61","doi-asserted-by":"crossref","unstructured":"Hanus, L., Abu-Lafi, S., Fride, E., Breuer, A., Vogel, Z., Shalev, D. E., Kustanovich, I. and Mechoulam, R. (2001) 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proceedings of the National Academy of Sciences of the United States of America98, 3662\u20133665.","DOI":"10.1073\/pnas.061029898"},{"key":"key\n\t\t\t\t20171011104327_B62","doi-asserted-by":"crossref","unstructured":"Herkenham, M., Lynn, A. B., Johnson, M. R., Melvin, L. S., de Costa, B. R. and Rice, K. C. (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. Journal of Neuroscience11, 563\u2013583.","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991"},{"key":"key\n\t\t\t\t20171011104327_B63","doi-asserted-by":"crossref","unstructured":"Hiley, C. R. and Ford, W. R. (2004) Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling. Biological Reviews of the Cambridge Philosophical Society79, 187\u2013205.","DOI":"10.1017\/S1464793103006201"},{"key":"key\n\t\t\t\t20171011104327_B64","unstructured":"Hillard, C. J., Manna, S., Greenberg, M. J., DiCamelli, R., Ross, R. A., Stevenson, L. A., Murphy, V., Pertwee, R. G. and Campbell, W. B. (1999) Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). Journal of Pharmacology and Experimental Therapeutics289, 1427\u20131433."},{"key":"key\n\t\t\t\t20171011104327_B65","doi-asserted-by":"crossref","unstructured":"Howlett, A. C., Barth, F., Bonner, T. I. et al. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacological Reviews54, 161\u2013202.","DOI":"10.1124\/pr.54.2.161"},{"key":"key\n\t\t\t\t20171011104327_B66","doi-asserted-by":"crossref","unstructured":"Howlett, A. C., Bidaut-Russell, M., Devane, W. A., Melvin, L. S., Johnson, M. R. and Herkenham, M. (1990) The cannabinoid receptor: biochemical, anatomical and behavioral characterization. Trends in Neurosciences13, 420\u2013423.","DOI":"10.1016\/0166-2236(90)90124-S"},{"key":"key\n\t\t\t\t20171011104327_B67","doi-asserted-by":"crossref","unstructured":"Hungund, B. L. and Basavarajappa, B. S. (2000) Are anandamide and cannabinoid receptors involved in ethanol tolerance? A review of the evidence. Alcohol and Alcoholism35, 126\u2013133.","DOI":"10.1093\/alcalc\/35.2.126"},{"key":"key\n\t\t\t\t20171011104327_B68","doi-asserted-by":"crossref","unstructured":"Hungund, B. L., Basavarajappa, B. S., Vadasz, C., Kunos, G., Rodriguez de Fonseca, F., Colombo, G., Serra, S., Parsons, L. and Koob, G. F. (2002) Ethanol, endocannabinoids, and the cannabinoidergic signaling system. Alcohol: Clinical and Experimental Research26, 565\u2013574.","DOI":"10.1111\/j.1530-0277.2002.tb02575.x"},{"key":"key\n\t\t\t\t20171011104327_B69","doi-asserted-by":"crossref","unstructured":"Izzo, A. A., Mascolo, N. and Capasso, F. (2001) The gastrointestinal pharmacology of cannabinoids. Current Opinion in Pharmacology11, 597\u2013603.","DOI":"10.1016\/S1471-4892(01)00102-3"},{"key":"key\n\t\t\t\t20171011104327_B70","doi-asserted-by":"crossref","unstructured":"Jagerovic, N., Hern\u00e1ndez-Folgado, L., Alkorta, I. et al. (2004) Discovery of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1h-1,2,4-triazole, a novel in vivo cannabinoid antagonist containing a 1,2,4-triazole motif. Journal of Medicinal Chemistry47, 2939\u20132942.","DOI":"10.1021\/jm031099y"},{"key":"key\n\t\t\t\t20171011104327_B71","doi-asserted-by":"crossref","unstructured":"Julian, M. D., Martin, A. B., Cuellar, B., Rodriguez de Fonseca, F., Navarro, M., Moratalla, R. and Garcia-Segura, L. M. (2003) Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia. Neuroscience119, 309\u2013318.","DOI":"10.1016\/S0306-4522(03)00070-8"},{"key":"key\n\t\t\t\t20171011104327_B72","doi-asserted-by":"crossref","unstructured":"Kathuria, S., Gaetani, S., Fegley, D. et al. (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nature Medicine9, 76\u201381.","DOI":"10.1038\/nm803"},{"key":"key\n\t\t\t\t20171011104327_B73","doi-asserted-by":"crossref","unstructured":"Kim, J., Isokawa, M., Ledent, C. and Alger, B. E. (2002) Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. Journal of Neuroscience22, 10182\u201310191.","DOI":"10.1523\/JNEUROSCI.22-23-10182.2002"},{"key":"key\n\t\t\t\t20171011104327_B74","doi-asserted-by":"crossref","unstructured":"Kunos, G., Batkai, S., Offertaler, L., Mo, F., Liu, J., Karcher, J. and Harvey-White, J. (2002) The quest for a vascular endothelial cannabinoid receptor. Chemistry and Physics of Lipids121, 45\u201356.","DOI":"10.1016\/S0009-3084(02)00145-7"},{"key":"key\n\t\t\t\t20171011104327_B75","doi-asserted-by":"crossref","unstructured":"Ledent, C., Valverde, O., Cossu, G. et al. (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science283, 401\u2013404.","DOI":"10.1126\/science.283.5400.401"},{"key":"key\n\t\t\t\t20171011104327_B76","doi-asserted-by":"crossref","unstructured":"Lichtman, A. H., Leung, D., Shelton, C., Saghatelian, A., Hardouin, C., Boger, D. and Cravatt, B. F. (2004) Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity. Journal of Pharmacology and Experimental Therapeutics. First published June 30, 2004, doi.10.1124\/jpet.104.069401.","DOI":"10.1124\/jpet.104.069401"},{"key":"key\n\t\t\t\t20171011104327_B77","doi-asserted-by":"crossref","unstructured":"Lopez-Rodriguez, M. L., Viso, A., Ortega-Gutierrez, S., Lastres-Becker, I., Gonzalez, S., Fernandez-Ruiz, J. and Ramos, J. A. (2001) Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors. Journal of Medicinal Chemistry44, 4505\u20134508.","DOI":"10.1021\/jm015545y"},{"key":"key\n\t\t\t\t20171011104327_B78","doi-asserted-by":"crossref","unstructured":"Mackie, K. and Hille, B. (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma\u2013glioma cells. Proceedings of the National Academy of Sciences of the United States of America89, 3825\u20133829.","DOI":"10.1073\/pnas.89.9.3825"},{"key":"key\n\t\t\t\t20171011104327_B79","doi-asserted-by":"crossref","unstructured":"Mackie, K., Lai, Y., Westenbroek, R. and Mitchell, R. (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. Journal of Neuroscience15, 6552\u20136561.","DOI":"10.1523\/JNEUROSCI.15-10-06552.1995"},{"key":"key\n\t\t\t\t20171011104327_B80","doi-asserted-by":"crossref","unstructured":"Maldonado, R. (2002) Study of cannabinoid dependence in animals. Pharmacology and Therapeutics95, 153\u2013164.","DOI":"10.1016\/S0163-7258(02)00254-1"},{"key":"key\n\t\t\t\t20171011104327_B81","doi-asserted-by":"crossref","unstructured":"Maldonado, R. and Rodriguez de Fonseca, F. (2002) Cannabinoid addiction: behavioral models and neural correlates. Journal of Neuroscience22, 3326\u20133321.","DOI":"10.1523\/JNEUROSCI.22-09-03326.2002"},{"key":"key\n\t\t\t\t20171011104327_B82","doi-asserted-by":"crossref","unstructured":"Manzanares, J., Corchero, J., Romero, J., Fernandez-Ruiz, J. J., Ramos, J. A. and Fuentes, J. A. (1999) Pharmacological and biochemical interactions between opioids and cannabinoids. Trends in Pharmacological Sciences20, 287\u2013294.","DOI":"10.1016\/S0165-6147(99)01339-5"},{"key":"key\n\t\t\t\t20171011104327_B83","doi-asserted-by":"crossref","unstructured":"Marsicano, G., Goodenough, S., Monory, K. et al. (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science302, 84\u201388.","DOI":"10.1126\/science.1088208"},{"key":"key\n\t\t\t\t20171011104327_B84","doi-asserted-by":"crossref","unstructured":"Marsicano, G., Wotjak, C. T., Azad, S. C. et al. (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature418, 530\u2013534.","DOI":"10.1038\/nature00839"},{"key":"key\n\t\t\t\t20171011104327_B85","doi-asserted-by":"crossref","unstructured":"Martin, B. R. and Lichtman, A. H. (1998) Cannabinoid transmission and pain perception. Neurobiology of Disease5, 447\u2013461.","DOI":"10.1006\/nbdi.1998.0218"},{"key":"key\n\t\t\t\t20171011104327_B86","doi-asserted-by":"crossref","unstructured":"Martin, B. R., Sim-Selley, L. J. and Selley, D. E. (2004) Signaling pathways involved in the development of cannabinoid tolerance. Trends in Pharmacological Sciences25, 325\u2013330.","DOI":"10.1016\/j.tips.2004.04.005"},{"key":"key\n\t\t\t\t20171011104327_B87","doi-asserted-by":"crossref","unstructured":"Matsuda, L. A. (1997) Molecular aspects of cannabinoid receptors. Critical Reviews in Neurobiology11, 143\u2013166.","DOI":"10.1615\/CritRevNeurobiol.v11.i2-3.30"},{"key":"key\n\t\t\t\t20171011104327_B88","doi-asserted-by":"crossref","unstructured":"Matsuda, L. A., Bonner, T. I. and Lolait, S. J. (1993) Localization of cannabinoid receptor mRNA in rat brain. Journal of Comparative Neurology327, 535\u2013550.","DOI":"10.1002\/cne.903270406"},{"key":"key\n\t\t\t\t20171011104327_B89","doi-asserted-by":"crossref","unstructured":"Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C. and Bonner, T. I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature346, 561\u2013564.","DOI":"10.1038\/346561a0"},{"key":"key\n\t\t\t\t20171011104327_B90","doi-asserted-by":"crossref","unstructured":"Mauler, F., Mittendorf, J., Horvath, E. and De Vry, J. (2002) Characterization of the diarylether sulfonylester (-)-(R)-3- (2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties. Journal of Pharmacology and Experimental Therapeutics302, 359\u2013368.","DOI":"10.1124\/jpet.302.1.359"},{"key":"key\n\t\t\t\t20171011104327_B91","doi-asserted-by":"crossref","unstructured":"Mechoulam, R. (1970) Marihuana chemistry. Science168, 1159\u20131166.","DOI":"10.1126\/science.168.3936.1159"},{"key":"key\n\t\t\t\t20171011104327_B92","doi-asserted-by":"crossref","unstructured":"Mechoulam, R., Ben-Shabat, S., Hanus, L. et al. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochemical Pharmacology50, 83\u201390.","DOI":"10.1016\/0006-2952(95)00109-D"},{"key":"key\n\t\t\t\t20171011104327_B93","doi-asserted-by":"crossref","unstructured":"Mechoulam, R. and Parker, L. (2003) Cannabis and alcohol \u2014 a close friendship. Trends in Pharmacological Sciences24, 266\u2013268.","DOI":"10.1016\/S0165-6147(03)00107-X"},{"key":"key\n\t\t\t\t20171011104327_B94","doi-asserted-by":"crossref","unstructured":"Molina-Holgado, F., Lled\u00f3, A. and Guaza, C. (1997) Anandamide suppresses nitric oxide and TNF-\u03b1 responses to Theiler's virus or endotoxin in astrocytes. Neuroreport8, 1929\u20131933.","DOI":"10.1097\/00001756-199705260-00027"},{"key":"key\n\t\t\t\t20171011104327_B95","doi-asserted-by":"crossref","unstructured":"Munro, S., Thomas, K. L. and Abu-Shaar, M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature365, 61\u201365.","DOI":"10.1038\/365061a0"},{"key":"key\n\t\t\t\t20171011104327_B96","doi-asserted-by":"crossref","unstructured":"Navarro, M., Carrera, M. R., Fratta, W. et al. (2001) Functional interaction between opioid and cannabinoid receptors in drug self-administration. Journal of Neuroscience21, 5344\u20135350.","DOI":"10.1523\/JNEUROSCI.21-14-05344.2001"},{"key":"key\n\t\t\t\t20171011104327_B97","doi-asserted-by":"crossref","unstructured":"Navarro, M., Hernandez, E., Munoz, R. M., del Arco, I., Villanua, M. A., Carrera, M. R. and Rodr\u00edguez de Fonseca, F. (1997) Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat. Neuroreport8, 491\u2013496.","DOI":"10.1097\/00001756-199701200-00023"},{"key":"key\n\t\t\t\t20171011104327_B98","doi-asserted-by":"crossref","unstructured":"Oka, S., Tsuchie, A., Tokumura, A., Muramatsu, M., Suhara, Y., Takayama, H., Waku, K. and Sugiura, T. (2003) Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species. Journal of Neurochemistry85, 1374\u20131381.","DOI":"10.1046\/j.1471-4159.2003.01804.x"},{"key":"key\n\t\t\t\t20171011104327_B99","doi-asserted-by":"crossref","unstructured":"Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T. and Ueda, N. (2004) Molecular characterization of a phospholipase D generating anandamide and its congeners. Journal of Biological Chemistry279, 5298\u20135305.","DOI":"10.1074\/jbc.M306642200"},{"key":"key\n\t\t\t\t20171011104327_B100","unstructured":"Pacheco, M., Childers, S. R., Arnold, R., Casiano, F. and Ward, S. J. (1991) Aminoalkylindoles: actions on specific G-protein-linked receptors. Journal of Pharmacology and Experimental Therapeutics257, 170\u2013183."},{"key":"key\n\t\t\t\t20171011104327_B101","doi-asserted-by":"crossref","unstructured":"Panikashvili, D., Simeonidou, C., Ben-Shabat, S., Hanus, L., Breuer, A., Mechoulam, R. and Shohami, E. (2001) An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature413, 527\u2013531.","DOI":"10.1038\/35097089"},{"key":"key\n\t\t\t\t20171011104327_B102","doi-asserted-by":"crossref","unstructured":"Pertwee, R. G. (2001) Cannabinoid receptors and pain. Progress in Neurobiology63, 569\u2013611.","DOI":"10.1016\/S0301-0082(00)00031-9"},{"key":"key\n\t\t\t\t20171011104327_B103","doi-asserted-by":"crossref","unstructured":"Piomelli, D. (2003) The molecular logic of endocannabinoid signalling. Nature Reviews Neuroscience4, 873\u2013884.","DOI":"10.1038\/nrn1247"},{"key":"key\n\t\t\t\t20171011104327_B104","doi-asserted-by":"crossref","unstructured":"Piomelli, D., Giuffrida, A., Calignano, A. and Rodr\u00edguez de Fonseca, F. (2000) The endocannabinoid system as a target for therapeutic drugs. Trends in Pharmacological Sciences21, 218\u2013224.","DOI":"10.1016\/S0165-6147(00)01482-6"},{"key":"key\n\t\t\t\t20171011104327_B105","doi-asserted-by":"crossref","unstructured":"Porter, A. C., Sauer, J. M., Knierman, M. D. et al. (2002) Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. Journal of Pharmacology and Experimental Therapeutics301, 1020\u20131024.","DOI":"10.1124\/jpet.301.3.1020"},{"key":"key\n\t\t\t\t20171011104327_B106","doi-asserted-by":"crossref","unstructured":"Randall, M. D., Harris, D., Kendall, D. A. and Ralevic, V. (2002) Cardiovascular effects of cannabinoids. Pharmacology and Therapeutics95, 191\u2013202.","DOI":"10.1016\/S0163-7258(02)00258-9"},{"key":"key\n\t\t\t\t20171011104327_B107","doi-asserted-by":"crossref","unstructured":"Rimondini, R., Arlinde, C., Sommer, W. and Heilig, M. (2002) Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol. The FASEB Journal16, 27\u201335.","DOI":"10.1096\/fj.01-0593com"},{"key":"key\n\t\t\t\t20171011104327_B108","doi-asserted-by":"crossref","unstructured":"Rinaldi-Carmona, M., Barth, F., Congy, C. et al. (2004) SR147778, a new potent and selective antagonist of the CB1 cannabinoid receptor. Biochemical and pharmacological characterization. Journal of Pharmacology and Experimental Therapeutics310, 905\u2013914.","DOI":"10.1124\/jpet.104.067884"},{"key":"key\n\t\t\t\t20171011104327_B109","doi-asserted-by":"crossref","unstructured":"Rinaldi-Carmona, M., Barth, F., H\u00e9aulme, M. et al. (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Letters350, 240\u2013244.","DOI":"10.1016\/0014-5793(94)00773-X"},{"key":"key\n\t\t\t\t20171011104327_B110","unstructured":"Rinaldi-Carmona, M., Barth, F., Millan, J. et al. (1998) SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. Journal of Pharmacology and Experimental Therapeutics284, 644\u2013650."},{"key":"key\n\t\t\t\t20171011104327_B111","doi-asserted-by":"crossref","unstructured":"Robbe, D., Kopf, M., Remaury, A., Bockaert, J. and Manzoni, O. J. (2002) Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proceedings of the National Academy of Sciences of the United States of America99, 8384\u20138348.","DOI":"10.1073\/pnas.122149199"},{"key":"key\n\t\t\t\t20171011104327_B112","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez de Fonseca, F., Carrera, M. R., Navarro, M., Koob, G. F., and Weiss, F. (1997) Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science276, 2050\u20132054.","DOI":"10.1126\/science.276.5321.2050"},{"key":"key\n\t\t\t\t20171011104327_B113","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez de Fonseca, F., Del Arco, I., Martin-Calderon, J. L., Gorriti, M. A. and Navarro, M. (1998) Role of the endogenous cannabinoid system in the regulation of motor activity. Neurobiology of Disease5, 483\u2013501.","DOI":"10.1006\/nbdi.1998.0217"},{"key":"key\n\t\t\t\t20171011104327_B114","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez de Fonseca, F., Navarro, M., Gomez, R., et al. (2001) An anorexic lipid mediator regulated by feeding. Nature414, 209\u2013212.","DOI":"10.1038\/35102582"},{"key":"key\n\t\t\t\t20171011104327_B115","unstructured":"Rodr\u00edguez de Fonseca, F., Roberts, A. J., Bilbao, A., Koob, G. F. and Navarro, M. (1999) Cannabinoid receptor antagonist SR141716A decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers. Zhongguo Yao Li Xue Bao20, 1109\u20131114."},{"key":"key\n\t\t\t\t20171011104327_B116","unstructured":"Rodr\u00edguez de Fonseca, F., Rubio, P., Menzaghi, F., Merlo-Pich, E., Rivier, J., Koob, G. F. and Navarro, M. (1996) Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive\u2013withdrawal behavior in rats. Journal of Pharmacology and Experimental Therapeutics276, 56\u201364."},{"key":"key\n\t\t\t\t20171011104327_B117","doi-asserted-by":"crossref","unstructured":"Rueda, D., Navarro, B., Martinez-Serrano, A., Guzman, M., Galve-Roperh, I. (2002) The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1\/B-Raf\/ERK pathway. Journal of Biological Chemistry277, 46645\u201346650.","DOI":"10.1074\/jbc.M206590200"},{"key":"key\n\t\t\t\t20171011104327_B118","unstructured":"Sanchez, C., de Ceballos, M. L., Del Pulgar, T. G. et al. (2001) Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. Cancer Research61, 5784\u20135789."},{"key":"key\n\t\t\t\t20171011104327_B119","doi-asserted-by":"crossref","unstructured":"Sanchis-Segura, C., Cline, B. H., Marsicano, G., Lutz, B. and Spanagel, R. (2004) Reduced sensitivity to reward in CB1 knockout mice. Psychopharmacology 2004 Apr 9.","DOI":"10.1007\/s00213-004-1877-8"},{"key":"key\n\t\t\t\t20171011104327_B120","doi-asserted-by":"crossref","unstructured":"Schlicker, E. and Kathmann, M. (2001) Modulation of transmitter release via presynaptic cannabinoid receptor. Trends in Pharmacological Sciences22, 565\u2013572.","DOI":"10.1016\/S0165-6147(00)01805-8"},{"key":"key\n\t\t\t\t20171011104327_B121","doi-asserted-by":"crossref","unstructured":"Schmidt, L. G., Samochowiec, J., Finckh, U., Fiszer-Piosik, E., Horodnicki, J., Wendel, B., Rommelspacher, H. and Hoehe, M. R. (2002) Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence. Drug and Alcohol Dependence65, 221\u2013224.","DOI":"10.1016\/S0376-8716(01)00164-8"},{"key":"key\n\t\t\t\t20171011104327_B122","doi-asserted-by":"crossref","unstructured":"Sipe, J. C., Chiang, K., Gerber, A. L., Beutler, E. and Cravatt, B. F. (2002) A missense mutation in human fatty acid amide hydrolase associated with problem drug use. Proceedings of the National Academy of Sciences of the United States of America99, 8394\u20138399.","DOI":"10.1073\/pnas.082235799"},{"key":"key\n\t\t\t\t20171011104327_B123","unstructured":"Smith, P. F. (2004) Medicinal cannabis extracts for the treatment of multiple sclerosis. Current Opinion in Investigational Drugs5, 727\u2013730."},{"key":"key\n\t\t\t\t20171011104327_B124","doi-asserted-by":"crossref","unstructured":"Stella, N. and Piomelli, D. (2001) Receptor-dependent formation of endogenous cannabinoids in cortical neurons. European Journal of Pharmacology425, 189\u2013196.","DOI":"10.1016\/S0014-2999(01)01182-7"},{"key":"key\n\t\t\t\t20171011104327_B125","doi-asserted-by":"crossref","unstructured":"Stella, N., Schweitzer, P. and Piomelli, D. (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature388, 773\u2013778.","DOI":"10.1038\/42015"},{"key":"key\n\t\t\t\t20171011104327_B126","doi-asserted-by":"crossref","unstructured":"Straiker, A., Stella, N., Piomelli, D., Mackie, K., Karten, H. J. and Maguire, G. (1999) Cannabinoid CB1 receptors and ligands in vertebrate retina: localization and function of an endogenous signaling system. Proceedings of the National Academy of Sciences of the United States of America96, 14565\u201314570.","DOI":"10.1073\/pnas.96.25.14565"},{"key":"key\n\t\t\t\t20171011104327_B127","doi-asserted-by":"crossref","unstructured":"Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A. and Waku, K. (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochemistry Biophysics Research Communications215, 89\u201397.","DOI":"10.1006\/bbrc.1995.2437"},{"key":"key\n\t\t\t\t20171011104327_B128","doi-asserted-by":"crossref","unstructured":"Tanda, G. and Goldberg, S. R. (2003) Cannabinoids: reward, dependence, and underlying neurochemical mechanisms \u2014 a review of recent preclinical data. Psychopharmacology169, 115\u2013134.","DOI":"10.1007\/s00213-003-1485-z"},{"key":"key\n\t\t\t\t20171011104327_B129","doi-asserted-by":"crossref","unstructured":"Tarzia, G., Duranti, A., Tontini, A., Piersanti, G., Mor, M., Rivara, S., Plazzi, P. V., Park, C., Kathuria, S. and Piomelli, D. (2003) Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors. Journal of Medicinal Chemistry46, 2352\u20132360.","DOI":"10.1021\/jm021119g"},{"key":"key\n\t\t\t\t20171011104327_B130","doi-asserted-by":"crossref","unstructured":"Tarzia, G., Duranti, A., Tontini, A., Spadoni, G., Mor, M., Rivara, S., Plazzi, P. V., Kathuria, S. and Piomelli, D. (2003) Synthesis and structure\u2013activity relationships of a series of pyrrole cannabinoid receptor agonists. Bioorganic and Medicinal Chemistry11, 3965\u20133973.","DOI":"10.1016\/S0968-0896(03)00413-9"},{"key":"key\n\t\t\t\t20171011104327_B131","doi-asserted-by":"crossref","unstructured":"Terranova, J. P., Storme, J. J., Lafon, N., Perio, A., Rinaldi-Carmona, M., Le Fur, G. and Soubri\u00e9, P. (1996) Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716. Psychopharmacology126, 165\u2013172.","DOI":"10.1007\/BF02246352"},{"key":"key\n\t\t\t\t20171011104327_B132","doi-asserted-by":"crossref","unstructured":"Tsou, K., Mackie, K., Sanudo-Pena, M. C. and Walker, J. M. (1999) Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation. Neuroscience93, 969\u2013975.","DOI":"10.1016\/S0306-4522(99)00086-X"},{"key":"key\n\t\t\t\t20171011104327_B133","doi-asserted-by":"crossref","unstructured":"Twitchell, W., Brown, S. and Mackie, K. (1997) Cannabinoids inhibit N- and P\/Q-type calcium channels in cultured rat hippocampal neurons. Journal of Neurophysiology78, 43\u201350.","DOI":"10.1152\/jn.1997.78.1.43"},{"key":"key\n\t\t\t\t20171011104327_B134","doi-asserted-by":"crossref","unstructured":"Varma, N., Carlson, G. C., Ledent, C. and Alger, B. E. (2001) Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. Journal of Neuroscience21, RC188.","DOI":"10.1523\/JNEUROSCI.21-24-j0003.2001"},{"key":"key\n\t\t\t\t20171011104327_B135","doi-asserted-by":"crossref","unstructured":"Wagner, J. A., Varga, K., Ellis, E. F., Rzigalinski, B. A., Martin, B. R. and Kunos, G. (1997) Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. Nature390, 518\u2013521.","DOI":"10.1038\/37371"},{"key":"key\n\t\t\t\t20171011104327_B136","doi-asserted-by":"crossref","unstructured":"Wilson, R. I., Kunos, G. and Nicoll, R. A. (2001) Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron31, 453\u2013462.","DOI":"10.1016\/S0896-6273(01)00372-5"},{"key":"key\n\t\t\t\t20171011104327_B137","doi-asserted-by":"crossref","unstructured":"Wilson, R. I. and Nicoll, R. A. (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature410, 588\u2013592.","DOI":"10.1038\/35069076"},{"key":"key\n\t\t\t\t20171011104327_B138","doi-asserted-by":"crossref","unstructured":"Wilson, R. I. and Nicoll, R. A. (2002) Endocannabinoid signaling in the brain. Science296, 678\u2013682.","DOI":"10.1126\/science.1063545"},{"key":"key\n\t\t\t\t20171011104327_B139","doi-asserted-by":"crossref","unstructured":"Witting, A., Walter, L., Wacker, J., Moller, T. and Stella, N. (2004) P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. Proceedings of the National Academy of Sciences of the United States of America101, 3214\u20133219.","DOI":"10.1073\/pnas.0306707101"},{"key":"key\n\t\t\t\t20171011104327_B140","doi-asserted-by":"crossref","unstructured":"Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H., S\u00f6rg\u00e4rd, M., Di Marzo, V., Julius, D. and H\u00f6gest\u00e4tt, E. D. (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature400, 452\u2013457.","DOI":"10.1038\/22761"}],"container-title":["Alcohol and Alcoholism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/alcalc\/article-pdf\/40\/1\/2\/791754\/agh110.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T01:32:51Z","timestamp":1585963971000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/alcalc\/article\/40\/1\/2\/282402\/THE-ENDOCANNABINOID-SYSTEM-PHYSIOLOGY-AND"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,18]]},"references-count":140,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,11,18]]},"published-print":{"date-parts":[[2005,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/alcalc\/agh110","relation":{},"ISSN":["1464-3502","0735-0414"],"issn-type":[{"value":"1464-3502","type":"electronic"},{"value":"0735-0414","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,1]]},"published":{"date-parts":[[2004,11,18]]}}}